- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT02228148
Comparison of the New Fitting Method Cochlear Nucleus Fitting Software (NFS) With the Established Fitting Method Cochlear Nucleus Custom SoundTM Suite (CSS)
January 9, 2018 updated by: Cochlear
Comparison of Fitting Methods Using Cochlear Clinical Care Innovation
The purpose of this study is to evaluate if the new and simplified fitting method with Cochlear Nucleus Fitting Software (a major component of a suite of tools which form the Clinical Care Innovation) provides Cochlear Implants Recipients with the same hearing outcome as the current and established clinical fitting method with Cochlear Nucleus Custom SoundTM Suite.
The Clinical Care Innovation method reduces fitting to simple volume, bass and trebles adjustments, operations which are familiar to anyone who has used an audio player.
Study Overview
Study Type
Interventional
Enrollment (Actual)
48
Phase
- Not Applicable
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Locations
-
-
Niedersachsen
-
Hannover, Niedersachsen, Germany, 30625
- Deutsches HörZentrum Hannover der HNO-Klinik der MHH
-
-
Schleswig-Holstein
-
Kiel, Schleswig-Holstein, Germany, 24105
- Universitätsklinikum Schleswig-Holstein - Campus Kiel, Klinik für Hals, Nasen-, Ohrenheilkunde, Kopf und Halschirurgie
-
-
-
-
Kanton Zurich
-
Zurich, Kanton Zurich, Switzerland, 8091
- Department of Otorhinolaryngology, Head and Neck Surgery, University Hospital
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
18 years and older (Adult, Older Adult)
Accepts Healthy Volunteers
No
Genders Eligible for Study
All
Description
Inclusion Criteria:
- Newly implanted subjects with available Nucleus Cochlear Implants compatible with CP900 series sound processors (excluding Cochlear Nucleus Hybrid)
- Post linguistically deafened adults (≥ 18 years)
- Unilaterally implanted
- ≤ 15 years of severe to profound deafness prior to implantation
- Subjects who are capable and willing to participate in speech perception tests in local language
- Subjects who are able to provide feedback in form of a written questionnaire (e.g. Speech Spatial Hearing Qualities questionnaire)
- Subjects willing to give their consent to the study
Exclusion Criteria:
- Additional handicaps that would prevent participation in evaluations (e.g. visual impairment, blindness)
- Unrealistic expectations on the part of the subject, regarding the possible benefits, risks and limitations that are inherent to the procedure/fitting method
- Bilateral implantation
- Hybrid-L (not supported by Nucleus Fitting Software)
- Subjects who already have hearing experience with a Cochlear Implant (e.g. reimplantation, contralateral Cochlear Implant)
- Subjects with single-sided deafness
- Known cochlea malformations
- Subjects who lost their hearing due to meningitis
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Primary Purpose: Supportive Care
- Allocation: Randomized
- Interventional Model: Crossover Assignment
- Masking: Double
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
Experimental: NFS
Cochlear Nucleus Fitting Software
|
Cochlear Nucleus Fitting Software
|
|
Active Comparator: CSS
Cochlear Nucleus Custom SoundTM Suite
|
Cochlear Nucleus Custom SoundTM Suite
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Speech perception performance in subjects fitted with Nucleus Fitting Software and subjects fitted with Nucleus Custom SoundTM Suite assessed via aided hearing thresholds
Time Frame: 3 months after implantation
|
Adaptive Oldenburg Sentence Test in noise with speech at 65 dB (if the subject's understanding with Oldenburg Sentence Test in quiet is ≥ 70%).
|
3 months after implantation
|
|
Speech perception performance in subjects fitted with Nucleus Fitting Software and subjects fitted with Nucleus Custom SoundTM Suite assessed via aided hearing thresholds
Time Frame: 6 months after implantation
|
Adaptive Oldenburg Sentence Test in noise with speech at 65 dB (if the subject's understanding with Oldenburg Sentence Test in quiet is ≥ 70%).
|
6 months after implantation
|
|
Speech perception performance in subjects fitted with Nucleus Fitting Software and subjects fitted with Nucleus Custom SoundTM Suite assessed via aided hearing thresholds
Time Frame: 9 months after implantation
|
Adaptive Oldenburg Sentence Test in noise with speech at 65 dB (if the subject's understanding with Oldenburg Sentence Test in quiet is ≥ 70%).
|
9 months after implantation
|
|
Speech perception performance in subjects fitted with Nucleus Fitting Software and subjects fitted with Nucleus Custom SoundTM Suite assessed via aided hearing thresholds
Time Frame: 12 months after implantation
|
Adaptive Oldenburg Sentence Test in noise with speech at 65 dB (if the subject's understanding with Oldenburg Sentence Test in quiet is ≥ 70%).
|
12 months after implantation
|
|
Speech perception performance in subjects fitted with Nucleus Fitting Software and subjects fitted with Nucleus Custom SoundTM Suite assessed via aided hearing thresholds
Time Frame: 15 months after implantation
|
Adaptive Oldenburg Sentence Test in noise with speech at 65 dB (if the subject's understanding with Oldenburg Sentence Test in quiet is ≥ 70%).
|
15 months after implantation
|
|
Speech perception performance in subjects fitted with Nucleus Fitting Software and subjects fitted with Nucleus Custom SoundTM Suite assessed via speech performance tests
Time Frame: 3 months after implantation
|
Freiburg Monosyllables and Oldenburg Sentence Test in quiet at 65 dB.
|
3 months after implantation
|
|
Speech perception performance in subjects fitted with Nucleus Fitting Software and subjects fitted with Nucleus Custom SoundTM Suite assessed via speech performance tests
Time Frame: 6 months after implantation
|
Freiburg Monosyllables and Oldenburg Sentence Test in quiet at 65 dB.
|
6 months after implantation
|
|
Speech perception performance in subjects fitted with Nucleus Fitting Software and subjects fitted with Nucleus Custom SoundTM Suite assessed via speech performance tests
Time Frame: 9 months after implantation
|
Freiburg Monosyllables and Oldenburg Sentence Test in quiet at 65 dB.
|
9 months after implantation
|
|
Speech perception performance in subjects fitted with Nucleus Fitting Software and subjects fitted with Nucleus Custom SoundTM Suite assessed via speech performance tests
Time Frame: 12 months after implantation
|
Freiburg Monosyllables and Oldenburg Sentence Test in quiet at 65 dB.
|
12 months after implantation
|
|
Speech perception performance in subjects fitted with Nucleus Fitting Software and subjects fitted with Nucleus Custom SoundTM Suite assessed via speech performance tests
Time Frame: 15 months after implantation
|
Freiburg Monosyllables and Oldenburg Sentence Test in quiet at 65 dB.
|
15 months after implantation
|
Secondary Outcome Measures
Outcome Measure |
Time Frame |
|---|---|
|
Hearing disability score in subjects fitted with Nucleus Fitting Software and subjects fitted with Nucleus Custom SoundTM Suite assessed via the Speech Spatial Hearing Qualities questionnaire (without spatial part)
Time Frame: before first fitting post-implantation (1 day)
|
before first fitting post-implantation (1 day)
|
|
Hearing disability score in subjects fitted with Nucleus Fitting Software and subjects fitted with Nucleus Custom SoundTM Suite assessed via the Speech Spatial Hearing Qualities questionnaire (without spatial part)
Time Frame: 3 months after implantation
|
3 months after implantation
|
|
Hearing disability score in subjects fitted with Nucleus Fitting Software and subjects fitted with Nucleus Custom SoundTM Suite assessed via the Speech Spatial Hearing Qualities questionnaire (without spatial part)
Time Frame: 6 months after implantation
|
6 months after implantation
|
|
Hearing disability score in subjects fitted with Nucleus Fitting Software and subjects fitted with Nucleus Custom SoundTM Suite assessed via the Speech Spatial Hearing Qualities questionnaire (without spatial part)
Time Frame: 9 months after implantation
|
9 months after implantation
|
|
Hearing disability score in subjects fitted with Nucleus Fitting Software and subjects fitted with Nucleus Custom SoundTM Suite assessed via the Speech Spatial Hearing Qualities questionnaire (without spatial part)
Time Frame: 12 months after implantation
|
12 months after implantation
|
|
Hearing disability score in subjects fitted with Nucleus Fitting Software and subjects fitted with Nucleus Custom SoundTM Suite assessed via the Speech Spatial Hearing Qualities questionnaire (without spatial part)
Time Frame: 15 months after implantation
|
15 months after implantation
|
|
Subject preference for fittings performed with Nucleus Fitting Software and fittings with Nucleus Custom SoundTM Suite assessed via a subject comfort questionnaire
Time Frame: after each fitting (4 weeks after implantation)
|
after each fitting (4 weeks after implantation)
|
|
Subject preference for fittings performed with Nucleus Fitting Software and fittings with Nucleus Custom SoundTM Suite assessed via a subject comfort questionnaire
Time Frame: after each fitting (3 months after implantation)
|
after each fitting (3 months after implantation)
|
|
Subject preference for fittings performed with Nucleus Fitting Software and fittings with Nucleus Custom SoundTM Suite assessed via a subject comfort questionnaire
Time Frame: after each fitting (6 months after implantation)
|
after each fitting (6 months after implantation)
|
|
Subject preference for fittings performed with Nucleus Fitting Software and fittings with Nucleus Custom SoundTM Suite assessed via a subject comfort questionnaire
Time Frame: after each fitting (9 months after implantation)
|
after each fitting (9 months after implantation)
|
|
Subject preference for fittings performed with Nucleus Fitting Software and fittings with Nucleus Custom SoundTM Suite assessed via a subject comfort questionnaire
Time Frame: after each fitting (12 months after implantation)
|
after each fitting (12 months after implantation)
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Sponsor
Collaborators
Investigators
- Study Director: Bart Volckaerts, PhD, Cochlear
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start
November 1, 2014
Primary Completion (Actual)
December 15, 2017
Study Completion (Actual)
December 15, 2017
Study Registration Dates
First Submitted
August 27, 2014
First Submitted That Met QC Criteria
August 27, 2014
First Posted (Estimate)
August 28, 2014
Study Record Updates
Last Update Posted (Actual)
January 10, 2018
Last Update Submitted That Met QC Criteria
January 9, 2018
Last Verified
January 1, 2018
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- CEL5332
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Hearing Loss
-
MED-EL Elektromedizinische Geräte GesmbHCompletedHearing Loss | Hearing Loss, Sensorineural | Hearing Loss, Bilateral | Hearing Loss, Conductive | Hearing Loss, Unilateral | Hearing Loss, MixedAustria, Germany, United Kingdom
-
Oticon MedicalCompletedEar Diseases | Hearing Loss, Conductive | Hearing Loss Mixed | Hearing Disability | Conductive Hearing Loss | Conductive Hearing Loss, Bilateral | Conductive Hearing Loss, UnilateralUnited Kingdom
-
Oticon MedicalNot yet recruitingSensorineural Hearing Loss, Bilateral | Sensorineural Hearing Loss, Severe | Sensorineural Hearing Loss, Profound
-
University of California, San FranciscoPatient-Centered Outcomes Research InstituteRecruitingHearing Loss | Hearing Loss, Sensorineural | Hearing Loss, Bilateral | Hearing Loss, Conductive | Hearing Loss, Noise-Induced | Hearing Loss, Unilateral | Hearing Loss, Mixed | Hearing Disorders in ChildrenUnited States
-
Manchester University NHS Foundation TrustUniversity of ManchesterCompletedCochlear Hearing Loss | Sensorineural Hearing Loss, BilateralUnited Kingdom
-
Truway Health, Inc.Enrolling by invitationSensorineural Hearing Loss | Tinnitus | Sudden Hearing Loss | Acoustic Trauma | Inner Ear Injury | Noise-Induced Hearing Loss | Vestibular DysfunctionUnited States
-
Envoy Medical CorporationActive, not recruitingSensorineural Hearing Loss | Sensorineural Hearing Loss (Disorder) | Sensorineural Hearing Loss, Bilateral | Sensorineural Hearing Loss, Severe | Sensorineural Hearing Loss, Profound | Sensori-Neural DeafnessUnited States
-
Oticon MedicalCompletedConductive Hearing Loss | Conductive and Sensori-neural Hearing Loss in the Same Ear | Unilateral, Profound Sensori-neural Hearing LossUnited States
-
Frequency TherapeuticsCompletedHearing Loss, Sensorineural | Presbycusis | Noise Induced Hearing Loss | Sudden Hearing LossUnited States
-
Frequency TherapeuticsCompletedHearing Loss, Sensorineural | Noise Induced Hearing Loss | Sudden Hearing LossUnited States
Clinical Trials on NFS
-
Neurophth Therapeutics IncTerminatedLeber Hereditary Optic Neuropathy (LHON)United States, China
-
University Hospital, LimogesCompleted
-
University Hospital, AntwerpRecruitingCardiovascular Diseases | Type 1 Diabetes | NAFLDBelgium
-
University Hospital, LimogesTerminatedSevere Sepsis | Inflammatory Response Syndrome, SystemicFrance